ArticleCancer immunology research2026

BET Inhibition Synergizes with RLR Signaling to Enhance Tumor Immunogenicity and T-cell Recognition.

Lucas Baldran-Groves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.